SCHEMBL22011804

SCHEMBL22011804

CCCCc1ccc(C2CCC(c3cc4oc5cc(-c6ccc(OCC)c(F)c6F)c(F)c(F)c5c4c(F)c3F)CC2)cc1

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 13/20 0.37
SPHK2 Q9NRA0 7/20 0.34
FFAR4 Q5NUL3 2/20 0.33
SSTR5 P35346 1/20 0.30
KDM1A O60341 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22011128 0.89 SPHK1 (0.45) SPHK1SPHK2FFAR4SSTR5
SCHEMBL22010988 0.81 MPL (0.37) FFAR4
SCHEMBL22011824 0.80 SPHK1 (0.40) SPHK1SPHK2
SCHEMBL22011219 0.79 SPHK1 (0.46) SPHK1SPHK2
SCHEMBL22011209 0.78 ACE2 (0.35) SPHK1SSTR5
SCHEMBL22011215 0.78 CYP2C9 (0.36) FFAR4KDM1A
SCHEMBL22011221 0.77 SPHK1 (0.34) SPHK1SPHK2FFAR4
SCHEMBL22011124 0.75 KDM1A (0.41) SSTR5KDM1A
SCHEMBL22011195 0.74 SCN9A (0.39)
SCHEMBL12733862 0.74 RARB (0.39) SPHK1SPHK2FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device YBX1, ZKSCAN2, RCC1 SPHK1 2249/4885SPHK2 2044/4885FFAR4 254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.